Is it useful performing pathology analysis on all samples from bronchoscopically accessible lung tumours?

G. Jifon, D. Butterworth, M. Winson (Crewe, United Kingdom)

Source: Annual Congress 2007 - Diagnosis of thoracic malignancies
Session: Diagnosis of thoracic malignancies
Session type: Thematic Poster Session
Number: 3883
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Jifon, D. Butterworth, M. Winson (Crewe, United Kingdom). Is it useful performing pathology analysis on all samples from bronchoscopically accessible lung tumours?. Eur Respir J 2007; 30: Suppl. 51, 3883

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Is bronchoscopic lung biopsy helpful in the management of patients with diffuse lung disease?
Source: Eur Respir J 2007; 29: 1064
Year: 2007


Blind bronchoscopic lung biopsy (BLB) as a primary approach to the evaluation of peripheral lung lesions
Source: Annual Congress 2009 - Trends in bronchoscopy
Year: 2009


Is virtual bronchoscopy (VB) useful in diagnosing of peripheral lung cancer?
Source: Eur Respir J 2007; 30: Suppl. 51, 667s
Year: 2007

Rinse fluid cytology specimens add value to standard bronchoscopic sampling techniques in the diagnosis of lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 361s
Year: 2003

Bronchoscopic findings in lung cancer: diagnostic yield of specimen collection method compared to histological type
Source: Eur Respir J 2005; 26: Suppl. 49, 534s
Year: 2005

The value of obtaining brushing samples in addition to biopsy and washings in the diagnosis of lung cancer
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Bronchoscopic brushing from central lung cancer – Next generation sequencing results are reliable
Source: International Congress 2019 – Diagnosis of lung cancer
Year: 2019

Transbronchial lung biopsy (TLB): still a valid tool to lung disease diagnosis?
Source: Eur Respir J 2006; 28: Suppl. 50, 516s
Year: 2006

Usefulness of various diagnostic techniques during fiberoptic bronchoscopy for endoscopically visible lung cancer: should cytologic examinations be performed routinely?
Source: Eur Respir J 2001; 18: Suppl. 33, 326s
Year: 2001

Lung cancer detection by computer assisted analysis of novel biomarkers in induced sputum samples
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008

Is an informative application a suitable tool for patients in a diagnostic lung cancer program?A qualitative study
Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases
Year: 2021


VATS lung biopsy is the method of choice for patients with ambiguous pulmonary pathology to establish a morphologic diagnosis
Source: Annual Congress 2011 - General thoracic surgery I
Year: 2011

The clinical value of autofluorescence bronchoscopy for the diagnosis of lung cancer
Source: Eur Respir J 2006; 28: 915-919
Year: 2006



Are surgical approaches for the solitary pulmonary nodule that are evaluated as malignant lung tumors acceptable?
Source: Eur Respir J 2005; 26: Suppl. 49, 172s
Year: 2005

The Choice of lung biopsy method in the presence of limited focal lesions.
Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease
Year: 2019

Updates in using a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples
Source: Breathe, 16 (3) 200067; 10.1183/20734735.0067-2020
Year: 2020



How do cytology samples compare with histology specimens when used for EGFR testing in patients with NSCLC?
Source: Annual Congress 2012 - Progress in endoscopy for lung cancer
Year: 2012


Is transbronchial lung biopsy using cryoprobes useful in the management of diffuse lung disease?
Source: Annual Congress 2013 –Interventional procedures for diagnosis of diffuse lung diseases and peripheral pulmonary lesions
Year: 2013

Nonsmall cell lung carcinoma: diagnostic difficulties in small biopsies and cytological specimens
Source: Eur Respir Rev, 26 (144) 170007; 10.1183/16000617.0007-2017
Year: 2017



HER-2/neu expression in bioptic and surgical samples of non small cell lung carcinoma
Source: Eur Respir J 2002; 20: Suppl. 38, 3s
Year: 2002